Medical Affairs @ AstraZeneca
Dr. Paul Newbold, PhD, is a Senior Medical Affairs Leader in the Respiratory Global Medical Affairs group of AstraZeneca. He has been with the AstraZenca/MedImmune organization for 23 years, always in the Respiratory and Inflammation therapeutic area. He has worked mainly on the development of new medicines (both small molecule and biologics) for asthma and Chronic Obstructive Pulmonary Disease (COPD). His interests have been in biomarker development for pharmacodynamic and pharmacological activity; understanding mechanism of action of disease and potential new therapies; predicting response to treatment; precision medicine; and early clinical trial design for proof of concept testing.
Paul has a PhD in Pharmacology from King’s College, London, and was a Post Doctoral Fellow at St Bartholomew’s Hospital, London, before joining AstraZeneca.